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ABSTRACT
Background: Atopic dermatitis (AD) and Japanese cedar pollinosis (JCP) are common chronically allergic
diseases associated with the activation of T-helper 2 cells. Recent studies have shown that polymorphisms in
the genes for IL-4 receptor α chain (IL4RA) may contribute to susceptibility of AD and JCP, although the differ-
ences in the involvements of loci of IL4RA gene between AD and JCP are unclear. In this study, we investi-
gated the role of polymorphisms in IL-4RA gene in conferring susceptibility to the development of AD andor
JCP using a family analysis and an association analysis in a Japanese population.
Methods: Five polymorphisms in the IL-4RA gene, C-3223T, T-1914C, T-890C, Ile50Val and Glu375Ala, have
been genotyped using PCR-based methods in 75 trios families, including 15 AD families, 30 JCP families, and
30 families with combination of AD and JCP in the family analysis. Forty-five AD, 60 JCP and 125 control chil-
dren constituted the association study.
Results: The transmission disequilibrium test showed that the allele of Ile50 was significantly transmitted to
children with JCP alone (p < 0.05). Haplotype analysis showed that the -3223TIle50 haplotype was preferen-
tially transmitted to both AD (p < 0.01) and JCP children (p < 0.01), while that the C-3223Ile50 haplotype was
preferentially transmitted to only JCP children (p < 0.01). The association study showed that -3223T and haplo-
type of -3223TIle50 were associated with AD children, but not with JCP. Ile50 was associated with both AD
and JCP.
Conclusions: Our data suggest that -3223T and the -3223TIle50 haplotype were risk factors for AD. Ile50 al-
lele seems to be involved in both JCP and AD. Interactions of the IL-4RA loci may play a role both conferring
susceptibility and modulating severity of AD.
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INTRODUCTION
Atopic dermatitis (AD) is a common, chronic and re-
current dermal inflammation with erythema, papule
and scale usually on the whole body that occurs with
increasing prevalence. It is characterized by hyperac-
tivated cytokines of helper T cell subset 2 and high
level of serum IgE.1,2 AD often accompanies other
atopic diseases such as asthma, Japanese cedar polli-
nosis (JCP) and conjunctivitis3-5 and is known to de-
velop by the interaction of genes and environment.6-9
JCP, defined as a type I allergic disease as well as
AD, has recently remarkably increased. It is one of
the most common forms of hay fever in Japan that de-
velops ocular and nasal symptoms paroxysmally upon
contact with Japanese cedar pollen in spring.10,11 The
seasonal symptoms are conjunctival itching and aller-
gic rhinitis such as sneezing, excessive nasal secre-
tion and nasal congestion. JCP is also considered to
be caused by the interaction of genes and environ-
ment.12
Interleukin 4 (IL4) is a pleiotropic cytokine pro-
duced by mast cells, basophils and T cells and plays a
central role in IgE-dependent inflammatory reac-
tions.13 IL4 is central to B cells’ switching to IgE anti-
body production, and to the maturation of T-helper
(Th) cells to the Th2 phenotype. IL4 operates
through the IL4 receptor (IL4R), a heterodimeric
complex comprising the IL4Rα chain (IL4RA) and γc
chain. Ober and his colleagues14 conducted a system-
atic search for variations in the IL4RA gene and found
13 polymorphic variants in the coding region, includ-
ing 7 variants that resulted in amino acid substitution.
Izuhara et al.15 have demonstrated that the preva-
lence of Ile50 is higher than that of 50Val in individu-
als with atopic asthma, especially in those in child-
hood in the Japanese. The Ile50Val variant of IL4RA
upregulates IgE synthesis and is associated with
atopic asthma.16
In our previous study, the Ile50Val variant of IL-4
RA has been demonstrated to be associated with the
development of JCP.12 Hesselmar et al.17 have com-
pared the relationships of C-3223T variant in IL4RA
between AD and pollen allergy, since AD accompa-
nies JCP.4 However, the contribution of IL-4RA poly-
morphisms to AD, JCP or both remain to be eluci-
dated well. Given the central role of the IL-4RA path-
way in AD and JCP, we have investigated the role of
five common polymorphisms in the IL-4RA gene,
three loci in promoter region (T-890C, T-1914C, C-
3223T), two in coding region (Ile50Val, Glu375Ala),
in conferring susceptibility to the development of AD
andor JCP using a family analysis and an association
analysis in a Japanese population.
METHODS
SUBJECTS
We recruited 950 subjects in Makioka-cho, a country
side area of Yamanashi Pref., and Shinagawa area of
Metropolitan Tokyo, Japan, who voluntarily received
the examination for the diagnosis of the AD and JCP
and for the study of its etiology. All subjects received
a self-administered questionnaire regarding their his-
tory of allergic diseases, i.e., JCP, asthma, and AD as
well as nasal and conjunctival symptoms: sneezing,
nasal discharge, itching of nasal mucosa or conjunc-
tiva, watering eyes. They underwent intradermal test
(IDT) and nasal provocation test (NPT) using house
dust, mite, ragweed, and Japanese cedar (Cryp-
tometria japonica). The diagnosis of AD was based on
standard criteria.18,19 The diagnosis of JCP was based
on the questionnaire, IDT, NPT, and a history of ce-
dar pollinosis. The criteria for diagnosis of cedar polli-
nosis were as follows: 1) under drug therapy or im-
munotherapy for cedar pollinosis, 2) at least one posi-
tive condition of IDT or NPT in subjects with symp-
toms. We performed a family study and an associa-
tion one using the subjects who were recruited in
Makioka-cho and Shinagawa area. All subjects were
fully informed of the protocol and had given their in-
formed consent before the experiment. This study
was approved by the Ethics Committee on Experi-
mentation of Kanazawa University.
Family Study
Sixty children under 16 years old, diagnosed with ce-
dar pollinosis according to the criteria and their 80
parents including 48 cedar pollinosis patients and 32
healthy subjects constituted the subjects of this
study. As 40 of 60 affected children were siblings, our
subjects included 40 families. The average ages ±
standard deviation of 60 children and their 80 patients
were 10.4 ± 3.20 years and 38.8 ± 3.42 years, respec-
tively. Total 15 children included fifteen children who
were diagnosed as AD, 30 children as JCP, and 30
children as the combination of AD and JCP. The aver-
age age ± standard deviation for 75 children and their
150 patients were 10.8 ± 3.10 years and 39.5 ± 33.4
years, respectively. There was no statistically signifi-
cant difference in the age among the three children
groups of AD, JCP, and the combination. The average
IgE value ± standard error of AD, JCP and controls
were 133 ± 25.8, 278 ± 42.1, and 37.5 ± 4.45 (Uml),
respectively. The IgE values in AD and JCP (both p <
0.001) were significantly higher than that in controls.
Association Study
We performed an association study in which 45 chil-
dren with AD alone and 60 children with JCP alone
were selected from unrelated subjects in Makioka-
cho and Shinagawa area, One-hundred twenty five
children were set as the control corresponding to the
patients by using balance match method for age and
sex. The controls did not show either symptoms of
AD, pollinosis, condition of IDT or NPT. All subjects
of the association study were selected differently
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Table　1　Transmission disequilibrium test (TDT) for IL4RA gene polymorphisms in 75 families including children with AD, JCP 
and combination of AD and JCP
Allele
AD (15 families) JCP (30 families) Combination (30 families)
Transmitted Not Transmitted Not Transmitted Not
-3223T 9 3 11 6 12 4
-1914C 7 2 11 5 11 3
-890C 1 0  0 1  1 0
Ile50 9 3 15* 3*  8 2
Glu375 4 1  6 2  6 2
*p = 0.0095 and 0.048 without and with correction for multiple comparisons by Bonferroni adjustment, respectively.
from those of the family study. The average ages ±
standard deviation of AD, JCP patients and control
groups in the association study were 10.2 ± 1.80, 10.5
± 1.92 and 10.1 ± 2.54 years, respectively. The aver-
age IgE value ± standard error of AD, JCP and con-
trols were 142 ± 27.6, 261 ± 30.0, and 43.4 ± 4.90 (U
ml), respectively. The values for AD and JCP (both p
< 0.001) were significantly higher than 43.4 ± 4.90 in
controls.
Total serum IgE was measured by enzyme immu-
noassay (TOSOH, Tokyo, Japan).
GENOTYPE
DNA was extracted from peripheral blood leukocytes
using the Automatic DNA Isolation System
(KURABO, Tokyo, Japan). Amplification was per-
formed using a Takara LA Taq (TAKARA, Kyoto,
Japan). The final reaction mixture (25 μl) consisted of
50 ng of genomic DNA (1 μl), 2.5 μl Taq buffer, 2 μl
dNTP, 0.125 μl Taq, 2 μl MgCl2 and 1 μl IL4RA vari-
ant specific primer pairs. The specific primer pairs
used were as follows: T-890C of promoter region of
IL4RA, forward 5’-TGTGTTCGAATCCCAGCTCC-3’
and reverse 5’-CCTGGCAACTACCCTATAAG-3’; T-
1914C of promoter region of IL4RA, forward 5’-GACT
TATCTTTACTGTCACT-3’ and reverse 5’-TTAGTAG
ACATGAGGTTTCA-3’; C-3223T of promoter region
of IL4RA, forward 5’-CGAAAGGCTTGGAAAGAAGT-
3’ and reverse 5’-TAGACCCACCTCATAGGGCTA-3’;
exon 5 of IL4RA, forward 5’-CGGAATTCCGAGGCCC
ACACGTGT-3’ and reverse 5’-CGCTGGGCTTGAAG
GAG-3’; exon 12 of IL4RA, forward 5’-ATCAGCGTGG
TGCGATGTGT-3’ and reverse 5’-GAATGAGGTCTT
GGAAAGG-3’. For IL4RA polymorphisms, the PCR
protocol consisted of a pre-PCR heat activation step
(95℃, 5 min) followed by 25 cycles of denaturation
(95℃, 1 min), annealing (55℃, 1 min), and extension
(72℃, 1 min), and final cycle extension at 72℃, 7
min. PCR products were visualized after agarose gel
electrophoresis and ethidium bromide staining. PCR
products were purified using of Microcon (Millipore,
Bedford, MA, USA).
We analyzed five polymorphisms of IL4RA gene
which Hackstein20 cited three loci in the promoter re-
gion (T-890C, T-1914C, C-3223T), the two in coding
region (Ile50Val, Glu375Ala). Nucleotide variants in
the promoter region are numbered according to the
relative position to exon 1 and the numbers of amino
acids correspond to the IL4RA mature protein which
is a membrane-bound receptor. Ile50Val (extracellu-
lar variant) and Glu375Ala (intracellular variant) are
in exon 5 and exon 12, respectively.
DNA SEQUENCING
Direct DNA sequencing of PCR products was per-
formed on an ABI Prism 377 Genetic Analyzer
(Perkin Elmer) using the ABI Prism Big Dye Termi-
nator DNA sequencing kit (Perkin Elmer).
STATISTICS
TDT was analyzed using Genehunter (version 2.1).
The calculations of haplotype, linkage disequilibrium
and Hardy-Weinberg equilibrium were computed by
employing the Arlequin software package (version
2.0), which implemented the EM algorithm to esti-
mate maximum likelihood haplotype frequencies.
The contributions of the IL4RA loci to the phenotypes
performed by the association study were assessed by
χ2 test and the odds ratio, as was analyzed by SPSS
(version 17.0J). P values obtained by the TDT and the
association study were corrected for multiple com-
parisons (Bonferroni adjustment according to the
number of comparisons made: Pcor = P-value x 5
(number of analyzed IL4RA variants)). The compari-
sons of total IgE value among AD, JCP and controls,
and among polymorphisms in the IL4RA genes were
analyzed using one-way analysis of variance, followed
by the multiple comparisons by Dunnett test. P val-
ues less than 0.05 were regarded as statistically sig-
nificant.
RESULTS
TDT
Table 1 showed the results of TDT in five polymor-
phisms in children with AD or JCP and combination
of AD and JCP. The allele of Ile50 was significantly
transmitted to children with JCP alone even after cor-
rection for multiple comparisons by Bonferroni ad-
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Table　2　Linkage disequilibrium parameter (D’) among C-
3223T, T-1914C and Ile50Val in children with 45 AD and 60
JCP
Allele
AD (45 children) JCP (60 children)
T-1914C Ile50Val T-1914C Ile50Val
C-3223T 0.286* 0.528*** 0.178 0.563***
T-1914C - 0.197 - 0.230*
*p < 0.05, ***p < 0.001.
Table　3　Frequencies of haplotypes of C-3223T, T-1914C
and Ile50Val in children with 45 AD and 60 JCP
Haplotype
AD JCP
A B C
0 0 0 0.300 0.352
1 0 1 0.175 0.155
1 1 1 0.172 0.120
0 0 1 0.097 0.060
0 1 0 0.091 0.074
1 1 0 0.069 0.067
0 1 1 0.056 0.173
1 0 0 0.039 0
A-0, C-3223; A-1, -3223T; B-0, T-1914; B-1, -1914C; C-0, 50Val; 
C-1, Ile50.
Table　4　Haplotype TDT in 45 families of children with AD 
and 60 with JCP
Haplotype
Observed/Expected
AD JCP
-3223T/Ile50 16/10** 17/9**
-3223T/50Val  3/6  4/7
C-3223/Ile50 11/8 14/8**
C-3223/50Val  4/6  4/6
**p < 0.01.
justment (p < 0.05). Nine children with AD whose Ile
50 allele were transmitted showed a higher propor-
tion as compared to 3 AD children whose Ile50 were
not, as was not significant. Similarly, 8 children with
the combination of AD and JCP whose Ile50 was
transmitted showed proportion as compared to 2 chil-
dren without transmission, as was not significant.
LINKAGE DISEQUILIBRIUM ANALYSIS
Significant linkage disequilibrium was observed be-
tween C-3223T and T-1914C (p < 0.05), and between
C-3223T and Ile50Val (p < 0.001) in AD children. In
JCP children, significant linkage disequilibrium was
observed between C-3223T and Ile50Val (p < 0.001),
and between T-1914C and Ile50Val (p < 0.05) (Table
2). Allele frequencies of C-3223T, T-1914C and Ile50
Val did not deviate from expected Hardy-Weinberg
equilibrium examined by χ2 test (p = 0.66, 0.47, and
0.40 in C-3223T, T-1914C, and Ile50Val for AD; p =
0.21, 0.15, and 0.71 in C-3223T, T-1914C, and Ile50Val
for JCP, respectively).
HAPLOTYPE ANALYSIS AND HAPLOTYPE TDT
As we found significant linkage disequilibrium in
three loci (C-3223T, T-1914C, and Ile50Val), we con-
ducted haplotype analysis of them. The frequencies
of three-locus haplotypes were shown in Table 3. The
frequencies of haplotypes other than these loci were
very low. In AD and JCP, the most common haplo-
type was allele 0-0-0 which means C-3223, T-1914 and
Val50. We performed haplotype TDT based on the
frequencies (Table 4). The -3223TIle50 haplotype
was preferentially transmitted to both AD and JCP
children (p < 0.01), while the C-3223Ile50 was pref-
erentially transmitted to only JCP children (p < 0.01).
ASSOCIATION STUDY
We recognized significant differences in allele fre-
quencies of two loci in IL4RA gene between controls
and AD or JCP (Table 5). The allele frequency in
-3223T, 44.4% in patients with AD showing a odds ra-
tio (95% confidence interval) of 1.98 (1.62-2.42) was
significantly higher than that in controls, even after
correcting for multiple comparisons by Bonferroni
adjustment (p < 0.05). However, we did not find a sig-
nificant difference in the C-3223T between controls
and JCP. On the contrary, the allele frequencies in
Ile50 in both AD and JCP were significantly higher
than that in control, even after adjustment by Bonfer-
roni method, showing odds ratios of 0.44 (0.36-0.55)
(p < 0.05) and 0.44 (0.37-0.52) (p < 0.01), respectively.
The frequency of -3223TIle50 haplotype in AD, but
not in JCP, was significantly higher that in control (χ2
= 31.6, p < 0.001).
There were significant differences in IgE value of
two loci in IL4RA gene among polymorphisms. The
multiple comparison by Dunnett method demon-
strated that the IgE value in CT allele of C-3223T
were significantly higher than that in CC allele (p <
0.01). The IgE value in IleIle allele were significantly
higher than that in ValVal (p < 0.01).
DISCUSSION
Many researchers have tried to identify variants of
the IL-4RA genes and have examined their associa-
tions with asthma, atopic dermatitis and cedar polli-
nosis.21 Systematic research has demonstrated poly-
morphic variants in the coding regions in the IL-4RA
gene, including 7 variants resulting in amino acid
substitution. Ile 50 Val, 22 Ser 487 Pro, 23 and
Gln551Arg21 have been reported to be involved in the
risk for hyper-IgE syndrome, atopic dermatitis, and
the asthma phenotype. Our previous study also dem-
onstrated that the polymorphism of Ile50Val in the IL-
IL4 RA Gene in Atopic Dermatitis
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Table　5　Association study for L4RA gene polymorphisms in 45 children with AD, and 60 children with JCP compared with 125 
controls
Gene Allele
Control AD JCP IgE value
(U/ml)‡Number Frequency† Number Frequency† Number Frequency†
C-3223T C/C 73 28.8 17 44.4 29 28.3  89.9 ± 10.5
C/T 32 16 28 162.5 ± 26.1**
T/T 20 12  3 125.9 ± 33.4
Odds ratio (5%-95% CI) 1.98 (1.62-2.42) 0.98 (0-100000)
p, corrected p value 0.010, 0.0498 0.976, 1
T-1914C T/T 70 26.4 23 30 29 28.33   120 ± 16.4
T/C 44 17 28 123.6 ± 19.4
C/C 11  5  3  95.3 ± 15.6
Odds ratio (5%-95% CI) 1.19 (0.33-4.36) 1.10 (0.076-16.0)
p, corrected p value 0.604, 1 0.7895, 1
T-890C T/T 120  2 41  4.44 58  1.67 121.4 ± 12.0
T/C 5  4  2  79.3 ± 28.1
C/C 0  0  0 119.4 ± 11.5
Odds ratio (5%-95% CI) 2.28 (0.25-20.7) 0.83 (0-100000)
p, corrected p value 0.392, 1 0.852, 1
Ile50Val Ile/Ile 52 37.6 31 21.1 38 20.8 149.7 ± 17.4##
Ile/Val 52  9 19   104 ± 18.8
Val/Val 21  5  3    35 ± 7.8
Odds ratio (5%-95% CI) 0.44 (0.36-0.55) 0.44 (0.37-0.52)
p, corrected p value 0.0066, 0.0329 0.0018, 0.0092
Glu375Ala Glu/Glu 110  6 42  3.33 55  4.17 119.8 ± 12.5
Glu/Ala 15  3  5 115.1 ± 28.3
Ala/Ala 0  0  0 119.4 ± 11.5
Odds ratio (5%-95% CI) 0.54 (0.04-6.61) 0.68 (0.03-16.8)
p, corrected p value 0.4875, 1 0.628, 1
†Frequency of minor allele (%), ‡Mean ± standard error, Statistical difference by Dunnett test as compared to the value of C-3223T,
**p < 0.01 and the value of 50Val, ##p < 0.01.
4RA gene was responsible for the development of
JCP.12 The substitution of Ile for Val augmented
STAT6 activation, proliferation, and transcription ac-
tivity of the promoter by IL-4,24 resulting in enhance-
ment of IgE synthesis and development of JCP. In
our association study, we also recognized that the
polymorphism of Ile50Val in the IL-4RA gene was as-
sociated with JCP and AD. Our results was supported
by the many other previous results that IL-4RA Ile50
was closely associated with JCP.12 Tanaka et al.25,26
suggested that AD patients with high IgE level was
associated with IL-4RA Ile50. Therefore, our results
examining AD patients showing a high IgE level is
considered to agree well with the assumption that IL-
4RA Ile50 plays a role in the production of IgE in AD
patients.
Ober et al.14 suggested that variations outside the
coding region of the IL-4RA gene influence suscepti-
bility to atopy and asthma. The polymorphisms in the
5’ promoter region of the IL-4RA were reported,20 e.g.
IL-4RA C-3223T and IL-4RA T-1914C are the distal
promoter polymorphisms. Usually the promoter poly-
morphisms might influence the transcription level of
the gene. Indeed, the promoter polymorphism, C to T
at position -3223 in the IL-4R gene was shown to influ-
ence the levels of the soluble IL-4RA (sIL-4RA) in se-
rum in Germany.20 Secreted forms of sIL-4RA occur
naturally in both mice and humans and have been de-
scribed to act as antagonists to IL-4.27 In vivo treat-
ment with sIL-4R, in a mouse model, prevented the
development of hypersensitivity and airway hyper-
responsiveness.28 While Hytonen et al.29 revealed the
C-3223T allele associated with lower serum levels of
sIL-4R and patients carrying the T allele also had se-
vere atopic asthma in Swedish Caucasians. In the pre-
sent study, we found novel strong linkage dise-
quilibria between C-3223T and Ile50Val in AD.
Hosomi and his colleagues30 demonstrated that the
IL-4RA gene polymorphisms in the distal prompter
region, C-3223T were significant associated with AD
in Japanese population. Novak et al.31 showed the
prevalence of the -3223T in IL4RA gene tended to be
Tanaka T et al.
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higher in AD than in nonatopic donors. Our findings
showed a higher IgE value in the subjects with C-
3223T as compared to C-3223C allele, suggesting that
-3223T as well as Ile50 are associated with a higher
IgE. Taken together, these findings suggest that the
C-3223T promoter polymorphism in the IL-4RA gene
plays a key role in development of AD.
In addition, we found that the -3223TIle50 haplo-
type was preferentially transmitted to AD children,
while that the C-3223 and -3223TIle50 haplotypes
were preferentially transmitted to JCP children. Fur-
thermore, the association study showed that -3223T
and haplotype of -3223TIle50 were associated with
AD children, but not with JCP. On the contrary, Ile50
was associated with both AD and JCP. These results
suggest that presence of 3223T allele and the -3223T
Ile50 haplotype were risk factors for AD, and that Ile
50 allele was for both JCP and AD. It is well known
that AD accompanies JC and that AD patients compli-
cated with JCP clinically tend to have more severe
AD symptoms.4 An exacerbation of AD lesions during
the Japanese cedar pollen season has been re-
ported.32 From these findings, it seems that combina-
tion of AD with JCP aggregates symptoms in AD pa-
tients. Both patients33 and dogs34 with AD showed
high concentration of allergen-specific IgE for Japa-
nese cedar pollen. We know that dogs sensitized by
Japanese cedar pollen allergens become to have
AD.35 Taken together, JCP are thought to be exacer-
bation factors for AD. Our results showing the in-
volvement of -3223TIle50 haplotype in AD suggest
that the concomitant of the two polymorphisms,
-3223T and Ile50 develop not only JCP and also AD.
In response to the problem of “spurious associa-
tions” to describe an association between a pheno-
type and a marker locus when the marker is unlinked
to any causative loci, Spielman et al.36 proposed the
transmission disequilibrium test (TDT), which uses
the genotypes of parents of affected individuals. In
the present study we used TDT, which method was
different from that of the association study between
the promoter region of IL-4RA and AD by Hosomi et
al..30 The TDT is not susceptible to spurious associa-
tions, but our samples were not so many trios fami-
lies. More subjects should be examined in further
studies using our procedures.
In conclusion, our results demonstrated the in-
volvements of -3223T allele and the -3223TIle50
haplotype in AD and that of Ile50 in AD and JCP, sug-
gesting that children with both -3223T and Ile50 may
develop AD. It seems likely that children with Ile50
alone develop JCP. Interactions of the IL-4RA loci
may play a role both conferring susceptibility and
modulating severity of AD.
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